Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety

Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety

Item
http://www.wikidata.org/entity/Q35958740
The approval process for biosimilar erythropoiesis-stimulating agentsThe cost of biologics for psoriasis is increasingComparability of biosimilar filgrastim with originator filgrastim: protein characterization, pharmacodynamics, and pharmacokinetics.Evaluation of Biosimilars for Formulary Inclusion: Factors for Consideration by P&T Committees.Biosimilars in Developed and Developing East and Southeast Asian Countries: Japan, South Korea, and Malaysia-Overview, Evolution, and Regulations Assessment.Biosimilars: part 2: potential concerns and challenges for p&t committees.Biosimilars: new promise for reducing healthcare costs.Insights on the use of biosimilars in the treatment of inflammatory bowel disease.Biosimilars: part 1: proposed regulatory criteria for FDA approval.Improving Access to Cancer Treatments: The Role of Biosimilars.The process defines the product: what really matters in biosimilar design and production?Biosimilars as a strategy to improve sustainability.A bibliometric analysis of the global research on biosimilars.Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
P2860

Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety

Item
http://www.wikidata.org/entity/Q35958740
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Innovation and Competition: Wi ...... re efficacy and patient safety
@ast
Innovation and Competition: Wi ...... re efficacy and patient safety
@en
type
label
Innovation and Competition: Wi ...... re efficacy and patient safety
@ast
Innovation and Competition: Wi ...... re efficacy and patient safety
@en
prefLabel
Innovation and Competition: Wi ...... re efficacy and patient safety
@ast
Innovation and Competition: Wi ...... re efficacy and patient safety
@en
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P932
P1433
P1476
Innovation and Competition: Wi ...... re efficacy and patient safety
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P932